Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Learn more about COPD to overcome the obstacle: Breathe better, Live more
- COPD Congress 2018

About Conference

Alliedacademies invites all the participants across the globe to attendthe 5th International Congress on Chronic ObstructivePulmonary Disease slated on June 25-26, 2018 in Amsterdam,Netherlands. 
Theme: Learn more about COPD to overcome the obstacle: Breathe better, Livemore

Allied Academies was founded by Jim and JoAnn Carland andthe headquarters is located in North Carolina in United States of America. Itconducts several academic conferences each year in different locations withinternet participation possibilities for those who are physically unable toattend the conferences. Conference registrants are eligible for the AcceleratedJournal Review. To provide you with maximum outlets for your research, AlliedBusiness Academies holds joint meetings of all its member academies. In 1994they launched the Journal of the International Academy of Case Studies, whichhas become a leader in publishing classroom teaching cases in business.

Why to attend COPDCongress 2018?
COPD Congress 2018 gives an excitingopportunity to meet with likeminded individuals and industry peers. Congressunites individuals from all different geographical areas who share a commondiscipline or field. Congress gives you the opportunity to converse with theseindividuals one-on-one about what they are really going after, and they mayeven give you guidance on how to enhance your own particular work. Atconference you have the opportunity to get feedback on your work fromindividuals who have never seen it before and may provide new insight. Brieflyit is an invest into yourself, your profession and your organization.
Many Chest Conferences have been organized throughout the yearacross the world and it has been noticed that “COPD” was the main topic of discussion.

Target Audience:

  •  Pulmonologists
  •  Allergists
  •  Academicians
  •  Research Scholars
  •  Professors
  •  Medical Students
  • Respiratory Specialists
  • Family Medicine and Primary care physicians
  • Radiologists
  •  Practitioners
  •  Physicians
  •  Nurses
  •  Clinical Researchers
  •  Business Entrepreneurs
  •  Software Developing Companies
  •  Medical Devices Companies
  •  Biomedical Companies
  •  Biotechnology Companies
  •  Data Management Companies
  •  Other Healthcare Professionals with an interest in COPD 

Welcome Message

On behalf of our Organizing Committee Members and Whole the team of COPD 2018, we cordially invite you to the 5th International Congress on Chronic Obstructive Pulmonary Disease, which is going to be organizing during June 25-26, 2018 at Amsterdam, Netherlands.

We invite Professional Speakers, Scientific Researchers, Students, and Delegates from both Academic and Business backgrounds to conduct Workshops, symposiums, Business Exhibitions, Oral, Poster and Video presentations, plenary sessions, keynote sessions by professionals all around the field of COPD to make your valuable exploration of your upcoming research works.

Sessions / Tracks

Track on Genetics of Chronic Obstructive Pulmonary Disease:

COPD is a type of the lung disease and highly prevalent disorder that causes from the interplay of genetic susceptibility. COPD is a lung infection that outcomes from checks in the aviation routes of the lungs that prompt breathing issues. COPD may be entangled by perpetual bronchitis or emphysema; a few patients create the two issues that prompt extra breathing issues. A few clinicians consider constant bronchitis and emphysema as essentially promote signs of COPD. Harm to the lung tissue after some time causes physical changes in the lungs and the aviation routes end up noticeably stopped up with thick bodily fluid. Consistence winds up plainly debilitated in light of this lung tissue harm. This debilitated consistence or versatility of the lungs implies that oxygen can't get to the air spaces where oxygen and carbon dioxide trade happens in the lung. This all prompts hacking to expel the thick bodily fluid and in the long run, trouble in relaxing.

It is found that not a single gene accounts for a major part of the expression but a polygenic model is responsible for gene control. The significant technological advances have been made in genetic evaluation of complex diseases, in COPD there is a deficiency of Alpha-1 Anti-trypsin (a rare inherited disorders). It can be influenced by environmental factors and cigarette smoking.

Track on Acute Exacerbation of COPD :

COPD exacerbations are also known as acute exacerbations which is a worsening of COPD symptoms. An acute exacerbation is defined as increased breath shortness, increased production of sputum. There are many causes of acute exacerbation are: Respiratory exacerbation, in which many bacteria (pathogens) and viruses, not only this but allergens, toxins and air pollution is also responsible for COPD. It can be prevented by vaccination against the pathogens and also by some agonists (long acting beta-adrenoceptor agonists (LABAs)), inhaled corticosteroids, antibiotics and antivirals.

Track on Chronic Pulmonary Hypertension :

Chronic Pulmonary hypertension is a type of increase blood pressure in the lungs arteries and right side of the heart.  Pulmonary hypertension symptoms include the breath shortness, chest pain and swelling of legs. In this hypertension, the pulmonary arterioles and capillaries become narrowed, destroyed and blocked, which makes the capillaries difficult to flow the blood through lungs.

Track on Asthma and Allergies:

Asthma is a typical long-term haul disease of the aviation routes of the lungs. It is described by factor and repeating manifestations, reversible wind current impediment, and bronchospasm. Symptoms incorporate scenes of wheezing, hacking, chest snugness, and shortness of breath.  These scenes may happen a couple of times each day or a couple of times for each week.  Depending on the individual, they may turn out to be more regrettable during the evening or with work out. Asthma is believed to be caused by a blend of hereditary and natural factors. Environmental variables incorporate presentation to air contamination and allergens. Other potential triggers incorporate prescriptions, for example, ibuprofen and beta blockers. Diagnosis is normally in light of the example of indications, reaction to treatment after some time, and Spirometry. Sensitivities may go about as a lung aggravation straightforwardly through unfavorably susceptible irritation, or in a roundabout way through hypersensitive rhinitis and postnasal dribble," he says. "Postnasal trickle may empower the nerves at the back of the nose, which can improve hack and exasperate COPD manifestations. COPD patients with sensitivities have more elevated amounts of respiratory side effects and are at a more serious hazard for an erupt.

Track on Tuberculosis:

Tuberculosis (TB) is an irresistible illness more often than not caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis for the most part influences the lungs, yet can likewise influence different parts of the body. Tuberculosis is spread through the air when individuals who have dynamic TB in their lungs hack, spit, talk, or wheeze. Individuals with idle TB don't spread the ailment. Dynamic contamination happens all the more regularly in individuals with HIV/AIDS and in the individuals who smoke. Conclusion of dynamic TB depends on chest X-beams, and also tiny examination and culture of body liquids. Finding of dormant TB depends on the tuberculin skin test (TST) or blood tests.

Track on Lung cancer:

Lung cancer, otherwise called lung carcinoma, is a threatening lung tumor portrayed by uncontrolled cell development in tissues of the lung. This development can spread past the lung by the procedure of metastasis into adjacent tissue or different parts of the body. Most growths that begin in the lung, known as essential lung malignancies, are carcinomas. The two principle sorts are little cell lung carcinoma (SCLC) and non-little cell lung carcinoma (NSCLC). The most well-known manifestations are hacking (counting hacking up blood), weight reduction, shortness of breath, and chest torments.

Track on Chronic bronchitis:

Chronic bronchitis is one sort of COPD (constant obstructive respiratory infection). The aggravated bronchial tubes deliver a great deal of bodily fluid. This prompts hacking and trouble relaxing. Cigarette smoking is the most widely recognized reason. Taking in air contamination, exhaust, or tidy over a drawn out stretch of time may likewise cause it.

Track on Alpha-1 Anti trypsin Deficiency:

Alpha-1 antitrypsin lack (Alpha1-antitrypsin insufficiency, A1AD, or AATD) is a hereditary issue that causes faulty creation of alpha-1 antitrypsin (A1AT), prompting diminished A1AT movement in the blood and lungs, and affidavit of intemperate irregular A1AT protein in liver cells. Inherited scatter that may cause lung illness and liver infection. Influenced people frequently create emphysema, which is a lung infection caused by harm to the little air sacs in the lungs (alveoli).

Track on COPD Epidemiology :

COPD Epidemiology is the review and investigation of the examples, causes, and impacts of chronic obstructive pulmonary disease in the population. According to the World Health Organization, COPD is the fourth foremost cause of death in the world, with almost 2.75 million deaths per annum, or 4.8% of deaths. In France, the mortality rate is approximately 40 deaths per 100,000 populations. At one time, COPD was more regular in men, but since of expanded tobacco use among ladies in high-wage nations and the higher danger of introduction to indoor air contamination in low-wage nations, this disease affects men and women almost equally.

Track on Obstructive lung disease:

Obstructive lung malady is a class of respiratory ailment portrayed via aviation route check. Numerous obstructive ailments of the lung come about because of narrowing of the littler bronchi and bigger bronchioles, frequently in view of extreme constriction of the smooth muscle itself. It is for the most part described by aroused and effectively collapsible aviation routes, impediment to wind current, issues breathing out and visit medicinal facility visits and hospitalizations. Sorts of obstructive lung ailment incorporate, asthma, bronchiectasis, bronchitis and constant obstructive pneumonic sickness (COPD).

Track on Pathophysiology and Pathogenesis of COPD :

The pathogenesis of COPD is that constant airflow restriction. Airspace inflammation appears to be diverse in vulnerable smokers and Chronic Inflammation includes a power of breathed in aggravations, for example, CD8+ T lymphocytes, neutrophils, and macrophages, B cells and macrophages together  when activated, these cells start an inflammatory cascade(tumor necrosis factor alpha) and prompts to structural changes. Airway rebuilding in COPD is an immediate consequence of the inflammatory response related with COPD and resulting in the narrowing of the airways. Chronic Inflammation may also be added by bacterial infection.

The diseases that includes under the COPD are: Chronic Bronchitis, Emphysema and COPD-Asthma overlap. Bronchitis causes inflammation and irritation of the airways in the lungs. Over time, this mucus plugs up airways and makes breathing difficult. Emphysema is a common type of COPD in which the lung’s air sacs become damaged and destroyed. This damaged area makes difficulty for the people with emphysema to expel air from their lungs. Asthma COPD Overlap Syndrome (ACOS) usually includes increased reversibility of airflow obstruction, systemic inflammation and eosinophilia bronchial.

Track on COPD and Cardiovascular Diseases :

COPD (lung illness) and cardiovascular infection (coronary illness) both offer tobacco (smoking) as a noteworthy hazard factor. Cardiovascular Disease essentially adds to both mortality and horribleness in COPD. People with never-ending obstructive aspiratory disease (COPD) or have a history or peril for cardiovascular ailment more much of the time encounter the evil impacts of heart strike and stroke. COPD triggers bothering and that, in this manner, prompts CVD, in light of the way that COPD increases incite particularly strange measures of disturbance, we pondered whether these escalations would be associated with higher rates of CVD events. The other hazard factors which are in charge of both COPD and Cardiovascular sickness that incorporates:

·    An inactive way of life adds to the characteristic history of each of these conditions. Novel components are engaged with the pathology and hereditary qualities of cardiovascular infection, and these may assume a vital part in driving the dangers related with COPD.

Track on Sleep Medicine:

Sleep drugs are a therapeutic strength or subspecialty dedicated to the determination and treatment of rest unsettling influences and scatters. Individuals with COPD may experience issues breathing, interminable hack, exhaustion, and chest fixing. COPD can likewise bring about lessened blood oxygen levels, making weariness and driving unfavorable wellbeing conditions. Rest issues and languor are regular in COPD patients, incompletely because of indications yet additionally due to the solutions used to treat COPD. Likewise, changes in breathing examples that happen amid ordinary rest that don't influence solid individuals may prompt more serious outcomes in individuals with COPD, which may decline and confuse COPD since they diminish blood oxygen. Indeed, even COPD patients without obstructive rest apnea (OSA) may encounter a drop in oxygen amid rest.

Track on Co-morbidities and COPD :

Comorbidities and chronic obstructive pulmonary disease (COPD) are ubiquitous. Comorbidities such as coronary artery disease, diabetes mellitus, osteoporosis, and hypertension and muscle weakness are commonly seen in the person with chronic obstructive pulmonary disease. Smoking of tobacco is a common factor for many of these comorbidities and COPD, making it tough to draw conclusions about the relationship between COPD and these comorbidities including Lung CancerPneumonia occurs when bacteria enter the lungs; which can weaken the lungs by creating an infection. This can lead to continuous illness and this downward spiral can lead to a rapid deterioration of health in COPD patient. Respiratory Insufficiency is a major complication of chronic obstructive pulmonary disease.

Track on Diagnostic Evaluation of COPD :

The detection and diagnosis of COPD can be evaluated by performing the following tests: Spirometry, CT scan, and Chest X-ray, Arterial blood gas analysis, Severity, complete blood count, transthoracic ultrasonography and Lung function tests. Spirometry measures the amount of airflow obstruction present and is generally done after the use of a bronchodilator. An Arterial blood gas test measures the oxygen level in blood and the result can show how severe COPD is and whether patient need oxygen therapy. The differential diagnosis is also performed for testing the asthma, congestive heart failure and pulmonary embolism.

Track on Prevention and management of COPD :

COPD Patients faces difficulty in clearing their lungs; with dusts, bacteria and other pollutants presents in surrounding atmosphere/environment. In most cases, COPD are potentially preventable through decreasing the smoke exposure and improving air quality. COPD exacerbations, hospitalizations and death can be cured by Influenza vaccination. It is known that, there is no alternative cure for COPD, but the symptoms are curely treatable and its progression can be delayed. It can be managed by the reducing the risk factors and by preventing and treating the acute exacerbation and associated illness. Breathing may be supported by Noninvasive ventilation.

Track on Therapies and treatment of pulmonary diseases:

Therapies and treatment mainly help to slow down the disease by quitting smoking and avoiding the triggers like air pollution. It improves the shortness of breath. 
Pulmonary Rehabilitation: It helps to train our mind, muscles, and heart to get the most out of damaged   lungs. Rehabilitation mainly combines exercise, therapy and breathing. It may include self-care and medications. Other treatments are as follows: Free oxygen treatment or therapy, Increase your overall health with regular activity, treatment for weakness of muscles, weight loss and proper medication.

Patients with the respiratory diseases, use some powerful devices for the removal of mucus from the airway, to improve the pulmonary functions. These devices present many benefits. Therapies mainly help to slow down the disease by quitting smoking and avoiding air pollution. It improves the shortness of breath. Some of the devices are - the High Frequency Chest Wall Oscillation, the Positive Expiratory Pressure, the Oral High Frequency Oscillation, and the Intrapulmonary Percussive Ventilation. Current devices seem to be effective in terms of pulmonary function improvement. Other treatments are as follows: Free oxygen treatment or therapy, Increase your overall health with regular activity, treatment for weakness of muscles, weight loss and proper medication.

Track on Advancement in Lung Surgeries:

Surgery is expected to take biopsies (tissue tests) of the lung for determination. Late advances in optic/video frameworks and endoscopic working instruments have made thoracoscopic less demanding and more exact than earlier years. The agent death rate has diminished (1%) and the demonstrative precision has expanded (99%). Thoracoscopy has been done at an expanding recurrence lately in light of its wide applications, particularly in the regions of helpful or agent methods, for example, carbon dioxide laser treatment of unconstrained pneumothorax or diffuse bullous emphysema and Lung volume diminishment and furthermore in the treatment of different aviation route infections. Two basic approaches to do surgery on your lungs are thoracotomy and video-helped thoracoscopic surgery (VATS). It includes passing an adaptive camera through little slices in the chest to look at the lungs or pleura (linings of the lung) under video direction and furthermore connected with lung transplantation.

Track on Pediatric Pulmonary and Health care:

Pediatric pulmonary study helps to provide comprehensive measure to children, infants and adults with a full spectrum of respiratory disorders. The major health care which should be taken for COPD are prescribed medications, maintain an active lifestyle approved by a doctor, aerobic exercise to increase the stamina and strengthening our body to improve the ability to breath. Avoid irritants like dust, air particles, and different odors. Get vaccination for pathogens (bacteria and viruses). Try to reduce the stress and eat the small meals throughout the day, drink plenty of fluids and the main important thing is to stop or to quit smoking.

Track on Respiratory Failure and Reactive airway disease:

Respiratory disappointment likewise can happen if your lungs can't legitimately expel carbon dioxide (a waste gas) from your blood. An excessive amount of carbon dioxide in your blood can hurt your body's organs. Respiratory disappointment comes about because of insufficient gas trade by the respiratory framework, implying that the blood vessel oxygen, carbon dioxide or both can't be kept at ordinary levels. A drop in the oxygen conveyed in blood is known as hypoxemia; an ascent in blood vessel carbon dioxide levels is called hypercapnia.

 

Market Analysis

  • Importance & Scope

    COPD Congress 2018 will be the best platform for all the Pulmonologists, Allergologist, Academicians, Research Scholars, Professors, Medical Students who are working in this field to exchange their knowledge related to COPD & Pulmonology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.
    Specialists will clarify how another era of treatment alternatives gives patients new trust in the battle against COPD.
    Geologically, the worldwide COPD research market is grouped mainly at; United Kingdom, Netherlands, United States, Austria, Germany, Europe, Asia-Pacific, Middle East, Japan, and Africa. 

    Why Amsterdam?
    Amsterdam is the capital and most populous municipality of the Kingdom of the Netherlands.

    Why to attend COPD Congress 2018??

    COPD Congress 2018 gives an exciting opportunity to meet with like-minded individuals and industry peers. Congress unites individuals from all different geographical areas who share a common discipline or field. Congress gives you the opportunity to converse with these individuals one-on-one about what they are really going after, and they may even give you guidance on how to enhance your own particular work. At conference you have the opportunity to get feedback on your work from individuals who have never seen it before and may provide new insight. Briefly it is an invest into yourself, your profession and your organization.

    Target Audience
    COPD Congress 2018 welcomes the Pulmonologists, Cardiologists, Academicians, Research Scholars, Professors, Medical Students, Practitioners, Physicians, Nurses, Clinical Researchers, Business Entrepreneurs, Software Developing Companies, Medical Devices Companies, Biomedical Companies, Biotechnology Companies, Data Management Companies and Other Healthcare Professionals with an interest in COPD to be a part of it.

    Major COPD Research Associations
    American Academy Of Allergy, Asthma & Immunology
    American Association For Respiratory Care
    Allergy/Asthma Information Association
    American Lung Association
    American Thoracic Society
    Asian Pacific Society Of Respirology
    Association Argentina De Medicina Respiratoria
    Australian Lung Foundation
    Association Of Bulgarians With Bronchial Asthma (Abba)
    Asthma Society Of Canada
    Asthma and Allergy Foundation of America
    Asthma UK
    Asthma and Allergy Association
    Asthma Australia
    Asthma and Respiratory Foundation NZ
    Breathe The Lung Association 
    British Lung Foundation
    British Thoracic Society
    Canadian Thoracic Society
    Chest Foundation
    Chinese COPD Patient Education Organization
    COPD Canada
    COPD Foundation
    COPD Thoracic Society
    COPD - Alert Support And Advocacy Group
    COPD - International
    COPD Patient Organization Of Vietnam
    COPD Patients Club Kyrgyzstan
    COPD Club Of Northern Thailand
    COPD Patient Organization Of Vietnam
    COPD Patients Club Kyrgyzstan
    European Respiratory Society
    European Lung Foundation
    Emphysema Foundation For Our Right To Survive
    Global Initiative For Chronic Obstructive Lung Disease
    Infectious Diseases Society Of America
    Irish Thoracic Society
    Lung Cancer Europe
    Lung Foundation Australia
    National Emphysema Foundation
    National Lung Health Education Program
    National Heart, Lung And Blood Institute, National Institutes Of Health
    Ontario Lung Association
    Pulmonary Fibrosis Foundation
    Pulmonary Fibrosis UK
    Pulmonary Education &Research Foundation
    Pulmonary Hypertension Association
    Respiratory Health Association
    The National Asthma Council Australia
    The Canadian Lung Association
    The International Association For The Study Of Lung Cancer

     


Major Universities

Australian National University, Australia

Charles Darwin University Casoria, Australia

Columbia University Medical  Center, United States

Curtin University Bentley, Australia

Dar Al Uloom University, Saudi Arabia

Harvard University, United States

Imperial College London, United Kingdom

Iqbal Chest Centre, Bangladesh

Johns Hopkins University, Maryland

Leiden University, Netherlands

Linnaeus University, Sweden

Maastricht University, Netherlands

Macquarie University, Australia

McGill University, Canada

Medi7 Bent Leigh, Australia

Tufts University, United States

University of Birmingham, United Kingdom

University of California, San Francisco

University  of California Los Angeles, United States

University of Colorado Boulder, United States

University of Groningen, Netherlands

University of Pittsburgh, Pennsylvania

University of Toronto, Canada

University of Washington, United States


Major Companies
Abbott Laboratories, US

Allergan Pharmaceutical, US

Almirall, Spain

Amgen Pharmaceutical, US
Amphastar Pharmaceuticals Inc.
AstraZeneca, Switzerland
Bayer, Germany
Beacon Pharmaceuticals Ltd, UK
Biotie Therapies, Finland
Boehringer Ingelheim Pharmaceut Inc., Germany
Chiesi Pharmaceutical, Italy
Cipla Limited, India
Cohero Health, US
Forest Laboratories, US
Gecko Health, US
GlaxoSmithKline Pharmaceutical, UK
North Carolina Biotechnology Center, England
Novartis International AG, Switzerland
Panmira Pharmaceuticals LLC
Pearl Therapeutics Inc.
PhRMA, America
Pfizer, US
Probiomics Ltd., Australia
Roche Holding AG, Switzerland
Sunovion, US
Vectura Group, UK






Market Report

Worldwide COPD market is measured to as of now be worth $11.3 billion, and is estimate to achieve an estimation of $15.6 billion by 2019. A current market research concentrate distributed by Transparency Market Research (TMR), the international asthma and COPD market was worth USD 25,102.3 million in 2010, which is relied upon to achieve USD 26,965.5 million in 2017 alongside a CAGR figure of 1.03% over the estimated by 2017.

According to a survey done by WHO; Chronic obstructive pulmonary disease will be the third leading cause of death world-wide causing considerable health costs, in 2020. Globally, it is assessed that 3 million deaths were caused by the COPD in 2015 (that is, 5% of all deaths comprehensively in that year). Over 90% of COPD deaths happen in low and middle-income countries.
In the coming five years, the global asthma and COPD medicate market is relied upon to develop gradually and immovable. In 2010, the asthma tranquilize section commanded the general asthma and COPD advertise at USD 14,509.1 million. A lot of this development will be driven by a high number of new, more viable and advantageous items entering the market and telling more notable esteem contrasted with the treatments as of now in the market. 
The asthma and COPD Therapies Market 2015-2025 report examines the current and future pharmaceutical treatments for these two respiratory diseases. With detailed numbers for both asthma and COPD indicating development everywhere throughout the world, understanding the market and the medications accessible is essential for each one of those in fields identified with the division. Presently, North America drives the worldwide market for asthma and COPD medications and gadgets. North America was trailed by Europe as far as market capitalization. Be that as it may, North America and Europe is relied upon to miss out a portion of the piece of the overall industry to other rising local markets inferable from the expiry of a few patens of pharmaceutical organizations working in these areas.


To Collaborate Scientific Professionals around the World

Conference Date June 25-26, 2018
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality


Join The Discussion

Allied Academies Global Conference Directory

Mail us at

For General Queries
copd@alliedconferences.org
For Registration
copd@alliedmeetings.org
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy


Copyright © 2017-2018 Allied Academies, All Rights Reserved.